Loading…

Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials

Age and infarct volume are strong predictors of outcome in patients with ischemic stroke who underwent endovascular therapy (EVT). We aimed to investigate the impact of ischemic core volume (ICV) on stroke outcome after EVT in elderly. Using the HERMES (Highly Effective Reperfusion Using Multiple En...

Full description

Saved in:
Bibliographic Details
Published in:Stroke (1970) 2022-12, Vol.53 (12), p.3564-3571
Main Authors: Tanaka, Koji, Goyal, Mayank, Menon, Bijoy K., Campbell, Bruce C.V., Mitchell, Peter J., Jovin, Tudor G., Dávalos, Antoni, Jansen, Olav, Muir, Keith W., White, Phil M., Bracard, Serge, Achit, Hamza, Dippel, Diederik W.J., Majoie, Charles B.L.M., Hill, Michael D., Brown, Scott, Demchuk, Andrew M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4497-8451f52cc9c10ca2246d07d9b8a193d3cc64c196f284d5e44a9dfd99d053d8d33
cites cdi_FETCH-LOGICAL-c4497-8451f52cc9c10ca2246d07d9b8a193d3cc64c196f284d5e44a9dfd99d053d8d33
container_end_page 3571
container_issue 12
container_start_page 3564
container_title Stroke (1970)
container_volume 53
creator Tanaka, Koji
Goyal, Mayank
Menon, Bijoy K.
Campbell, Bruce C.V.
Mitchell, Peter J.
Jovin, Tudor G.
Dávalos, Antoni
Jansen, Olav
Muir, Keith W.
White, Phil M.
Bracard, Serge
Achit, Hamza
Dippel, Diederik W.J.
Majoie, Charles B.L.M.
Hill, Michael D.
Brown, Scott
Demchuk, Andrew M.
description Age and infarct volume are strong predictors of outcome in patients with ischemic stroke who underwent endovascular therapy (EVT). We aimed to investigate the impact of ischemic core volume (ICV) on stroke outcome after EVT in elderly. Using the HERMES (Highly Effective Reperfusion Using Multiple Endovascular Devices) collaboration, a patient-level meta-analysis of 7 randomized trials in which patients were enrolled from December 2010 to April 2015) dataset, we categorized patients into those aged
doi_str_mv 10.1161/STROKEAHA.122.039774
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2733201921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2733201921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4497-8451f52cc9c10ca2246d07d9b8a193d3cc64c196f284d5e44a9dfd99d053d8d33</originalsourceid><addsrcrecordid>eNpFkU1uE0EQhUeIiJjADRCqJZsx_Tc_zW4wDrESyRE2SKxGne6auEnPtNM9k8hH4CBcgCNxkkziJKye6um9Kqm-JHlHyZTSnH5crb8tT-fVSTWljE0Jl0UhXiQTmjGRipyVL5MJGd2UCSkPk9cx_iKEMF5mr5JDnnNekExMkr8re9nZxmrVaQTfwGcV0dkOYRH1BlurYeYDwg_vhnYMdLDqg79CWA699qNTNT0GmHfG36ioB6cCrDcY1HYHtoNz1Vvs-gjVJcK_33-KDH6iCvETVHDuvUMDVafcLtp4f3zRGXtjzaDcUxO-qF7BcfAtFLAOVrn4JjloRsG3j3qUfD-er2cn6dny62JWnaVaCFmkpchokzGtpaZEK8ZEbkhh5EWpqOSGa50LTWXesFKYDIVQ0jRGSkMybkrD-VHyYb93G_z1gLGvWxs1Oqc69EOsWcE5I1QyOkbFPqqDjzFgU2-DbVXY1ZTU97TqZ1r1SKve0xpr7x8vDBctmufSE57_e2-9G98cr9xwi6HeoHL9ph55kiIvSMoIY5SNU_pg8TtleaJs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2733201921</pqid></control><display><type>article</type><title>Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials</title><source>Alma/SFX Local Collection</source><creator>Tanaka, Koji ; Goyal, Mayank ; Menon, Bijoy K. ; Campbell, Bruce C.V. ; Mitchell, Peter J. ; Jovin, Tudor G. ; Dávalos, Antoni ; Jansen, Olav ; Muir, Keith W. ; White, Phil M. ; Bracard, Serge ; Achit, Hamza ; Dippel, Diederik W.J. ; Majoie, Charles B.L.M. ; Hill, Michael D. ; Brown, Scott ; Demchuk, Andrew M.</creator><creatorcontrib>Tanaka, Koji ; Goyal, Mayank ; Menon, Bijoy K. ; Campbell, Bruce C.V. ; Mitchell, Peter J. ; Jovin, Tudor G. ; Dávalos, Antoni ; Jansen, Olav ; Muir, Keith W. ; White, Phil M. ; Bracard, Serge ; Achit, Hamza ; Dippel, Diederik W.J. ; Majoie, Charles B.L.M. ; Hill, Michael D. ; Brown, Scott ; Demchuk, Andrew M. ; HERMES Collaborators ; on behalf of the HERMES Collaborators</creatorcontrib><description>Age and infarct volume are strong predictors of outcome in patients with ischemic stroke who underwent endovascular therapy (EVT). We aimed to investigate the impact of ischemic core volume (ICV) on stroke outcome after EVT in elderly. Using the HERMES (Highly Effective Reperfusion Using Multiple Endovascular Devices) collaboration, a patient-level meta-analysis of 7 randomized trials in which patients were enrolled from December 2010 to April 2015) dataset, we categorized patients into those aged &lt;75 and ≥75 years. ICV was calculated on computed tomography perfusion or magnetic resonance diffusion-weighted imaging. The association between ICV and the benefit of EVT over best medical treatment on outcome (modified Rankin Scale [mRS] at 90 days) and an ICV threshold for high likelihood (≥90%) of very poor outcome (mRS score ≥5) after EVT were investigated. A total of 899 patients who had baseline ICV data, 247 patients aged ≥75 years, of which 118 were randomized in the EVT arm. Patients aged ≥75 years required smaller ICV to achieve mRS score ≤3 than those aged &lt;75 years in the EVT arm (median 10.7 mL versus 23.9 mL, &lt;0.001). In patients aged ≥75 years, modeling of outcome in both treatment arms revealed potential loss of effect for EVT at ICV of ≥50 mL or ≥85 mL for achieving mRS score ≤3 or ≤4, respectively. Treatment effect of EVT was significant in ICV &lt;50 mL for mRS ≤3 (odds ratio 2.38, 95% confidence interval 1.35-4.22). ICV ≥132 mL was a threshold for high likelihood of very poor outcome after EVT. However, EVT still predicted at least 30% rate of mRS ≤3 at 150 mL ICV if near-complete or complete reperfusion was achieved. Baseline ICV has an impact on stroke outcome after EVT in the elderly, but elderly patients with large ICV may still benefit from EVT if near-complete or complete reperfusion is achieved. Young patients seem to benefit from EVT regardless of ICV status.</description><identifier>ISSN: 0039-2499</identifier><identifier>EISSN: 1524-4628</identifier><identifier>DOI: 10.1161/STROKEAHA.122.039774</identifier><identifier>PMID: 36337054</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins</publisher><subject>Aged ; Brain Ischemia - diagnostic imaging ; Brain Ischemia - surgery ; Endovascular Procedures - methods ; Humans ; Randomized Controlled Trials as Topic ; Reperfusion ; Stroke - diagnostic imaging ; Stroke - surgery ; Thrombectomy - methods ; Treatment Outcome</subject><ispartof>Stroke (1970), 2022-12, Vol.53 (12), p.3564-3571</ispartof><rights>Lippincott Williams &amp; Wilkins</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4497-8451f52cc9c10ca2246d07d9b8a193d3cc64c196f284d5e44a9dfd99d053d8d33</citedby><cites>FETCH-LOGICAL-c4497-8451f52cc9c10ca2246d07d9b8a193d3cc64c196f284d5e44a9dfd99d053d8d33</cites><orcidid>0000-0002-4930-7789 ; 0000-0001-6501-4057 ; 0000-0003-2949-5679 ; 0000-0002-3466-496X ; 0000-0002-6269-1543 ; 0000-0001-9535-022X ; 0000-0003-3632-9433 ; 0000-0002-2619-6975 ; 0000-0001-9060-2109 ; 0000-0002-0040-3251 ; 0000-0002-8337-7529 ; 0000-0002-7600-9568 ; 0000-0002-9234-3515 ; 0000-0002-7330-1942</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36337054$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanaka, Koji</creatorcontrib><creatorcontrib>Goyal, Mayank</creatorcontrib><creatorcontrib>Menon, Bijoy K.</creatorcontrib><creatorcontrib>Campbell, Bruce C.V.</creatorcontrib><creatorcontrib>Mitchell, Peter J.</creatorcontrib><creatorcontrib>Jovin, Tudor G.</creatorcontrib><creatorcontrib>Dávalos, Antoni</creatorcontrib><creatorcontrib>Jansen, Olav</creatorcontrib><creatorcontrib>Muir, Keith W.</creatorcontrib><creatorcontrib>White, Phil M.</creatorcontrib><creatorcontrib>Bracard, Serge</creatorcontrib><creatorcontrib>Achit, Hamza</creatorcontrib><creatorcontrib>Dippel, Diederik W.J.</creatorcontrib><creatorcontrib>Majoie, Charles B.L.M.</creatorcontrib><creatorcontrib>Hill, Michael D.</creatorcontrib><creatorcontrib>Brown, Scott</creatorcontrib><creatorcontrib>Demchuk, Andrew M.</creatorcontrib><creatorcontrib>HERMES Collaborators</creatorcontrib><creatorcontrib>on behalf of the HERMES Collaborators</creatorcontrib><title>Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials</title><title>Stroke (1970)</title><addtitle>Stroke</addtitle><description>Age and infarct volume are strong predictors of outcome in patients with ischemic stroke who underwent endovascular therapy (EVT). We aimed to investigate the impact of ischemic core volume (ICV) on stroke outcome after EVT in elderly. Using the HERMES (Highly Effective Reperfusion Using Multiple Endovascular Devices) collaboration, a patient-level meta-analysis of 7 randomized trials in which patients were enrolled from December 2010 to April 2015) dataset, we categorized patients into those aged &lt;75 and ≥75 years. ICV was calculated on computed tomography perfusion or magnetic resonance diffusion-weighted imaging. The association between ICV and the benefit of EVT over best medical treatment on outcome (modified Rankin Scale [mRS] at 90 days) and an ICV threshold for high likelihood (≥90%) of very poor outcome (mRS score ≥5) after EVT were investigated. A total of 899 patients who had baseline ICV data, 247 patients aged ≥75 years, of which 118 were randomized in the EVT arm. Patients aged ≥75 years required smaller ICV to achieve mRS score ≤3 than those aged &lt;75 years in the EVT arm (median 10.7 mL versus 23.9 mL, &lt;0.001). In patients aged ≥75 years, modeling of outcome in both treatment arms revealed potential loss of effect for EVT at ICV of ≥50 mL or ≥85 mL for achieving mRS score ≤3 or ≤4, respectively. Treatment effect of EVT was significant in ICV &lt;50 mL for mRS ≤3 (odds ratio 2.38, 95% confidence interval 1.35-4.22). ICV ≥132 mL was a threshold for high likelihood of very poor outcome after EVT. However, EVT still predicted at least 30% rate of mRS ≤3 at 150 mL ICV if near-complete or complete reperfusion was achieved. Baseline ICV has an impact on stroke outcome after EVT in the elderly, but elderly patients with large ICV may still benefit from EVT if near-complete or complete reperfusion is achieved. Young patients seem to benefit from EVT regardless of ICV status.</description><subject>Aged</subject><subject>Brain Ischemia - diagnostic imaging</subject><subject>Brain Ischemia - surgery</subject><subject>Endovascular Procedures - methods</subject><subject>Humans</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Reperfusion</subject><subject>Stroke - diagnostic imaging</subject><subject>Stroke - surgery</subject><subject>Thrombectomy - methods</subject><subject>Treatment Outcome</subject><issn>0039-2499</issn><issn>1524-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpFkU1uE0EQhUeIiJjADRCqJZsx_Tc_zW4wDrESyRE2SKxGne6auEnPtNM9k8hH4CBcgCNxkkziJKye6um9Kqm-JHlHyZTSnH5crb8tT-fVSTWljE0Jl0UhXiQTmjGRipyVL5MJGd2UCSkPk9cx_iKEMF5mr5JDnnNekExMkr8re9nZxmrVaQTfwGcV0dkOYRH1BlurYeYDwg_vhnYMdLDqg79CWA699qNTNT0GmHfG36ioB6cCrDcY1HYHtoNz1Vvs-gjVJcK_33-KDH6iCvETVHDuvUMDVafcLtp4f3zRGXtjzaDcUxO-qF7BcfAtFLAOVrn4JjloRsG3j3qUfD-er2cn6dny62JWnaVaCFmkpchokzGtpaZEK8ZEbkhh5EWpqOSGa50LTWXesFKYDIVQ0jRGSkMybkrD-VHyYb93G_z1gLGvWxs1Oqc69EOsWcE5I1QyOkbFPqqDjzFgU2-DbVXY1ZTU97TqZ1r1SKve0xpr7x8vDBctmufSE57_e2-9G98cr9xwi6HeoHL9ph55kiIvSMoIY5SNU_pg8TtleaJs</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Tanaka, Koji</creator><creator>Goyal, Mayank</creator><creator>Menon, Bijoy K.</creator><creator>Campbell, Bruce C.V.</creator><creator>Mitchell, Peter J.</creator><creator>Jovin, Tudor G.</creator><creator>Dávalos, Antoni</creator><creator>Jansen, Olav</creator><creator>Muir, Keith W.</creator><creator>White, Phil M.</creator><creator>Bracard, Serge</creator><creator>Achit, Hamza</creator><creator>Dippel, Diederik W.J.</creator><creator>Majoie, Charles B.L.M.</creator><creator>Hill, Michael D.</creator><creator>Brown, Scott</creator><creator>Demchuk, Andrew M.</creator><general>Lippincott Williams &amp; Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4930-7789</orcidid><orcidid>https://orcid.org/0000-0001-6501-4057</orcidid><orcidid>https://orcid.org/0000-0003-2949-5679</orcidid><orcidid>https://orcid.org/0000-0002-3466-496X</orcidid><orcidid>https://orcid.org/0000-0002-6269-1543</orcidid><orcidid>https://orcid.org/0000-0001-9535-022X</orcidid><orcidid>https://orcid.org/0000-0003-3632-9433</orcidid><orcidid>https://orcid.org/0000-0002-2619-6975</orcidid><orcidid>https://orcid.org/0000-0001-9060-2109</orcidid><orcidid>https://orcid.org/0000-0002-0040-3251</orcidid><orcidid>https://orcid.org/0000-0002-8337-7529</orcidid><orcidid>https://orcid.org/0000-0002-7600-9568</orcidid><orcidid>https://orcid.org/0000-0002-9234-3515</orcidid><orcidid>https://orcid.org/0000-0002-7330-1942</orcidid></search><sort><creationdate>20221201</creationdate><title>Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials</title><author>Tanaka, Koji ; Goyal, Mayank ; Menon, Bijoy K. ; Campbell, Bruce C.V. ; Mitchell, Peter J. ; Jovin, Tudor G. ; Dávalos, Antoni ; Jansen, Olav ; Muir, Keith W. ; White, Phil M. ; Bracard, Serge ; Achit, Hamza ; Dippel, Diederik W.J. ; Majoie, Charles B.L.M. ; Hill, Michael D. ; Brown, Scott ; Demchuk, Andrew M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4497-8451f52cc9c10ca2246d07d9b8a193d3cc64c196f284d5e44a9dfd99d053d8d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Brain Ischemia - diagnostic imaging</topic><topic>Brain Ischemia - surgery</topic><topic>Endovascular Procedures - methods</topic><topic>Humans</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Reperfusion</topic><topic>Stroke - diagnostic imaging</topic><topic>Stroke - surgery</topic><topic>Thrombectomy - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanaka, Koji</creatorcontrib><creatorcontrib>Goyal, Mayank</creatorcontrib><creatorcontrib>Menon, Bijoy K.</creatorcontrib><creatorcontrib>Campbell, Bruce C.V.</creatorcontrib><creatorcontrib>Mitchell, Peter J.</creatorcontrib><creatorcontrib>Jovin, Tudor G.</creatorcontrib><creatorcontrib>Dávalos, Antoni</creatorcontrib><creatorcontrib>Jansen, Olav</creatorcontrib><creatorcontrib>Muir, Keith W.</creatorcontrib><creatorcontrib>White, Phil M.</creatorcontrib><creatorcontrib>Bracard, Serge</creatorcontrib><creatorcontrib>Achit, Hamza</creatorcontrib><creatorcontrib>Dippel, Diederik W.J.</creatorcontrib><creatorcontrib>Majoie, Charles B.L.M.</creatorcontrib><creatorcontrib>Hill, Michael D.</creatorcontrib><creatorcontrib>Brown, Scott</creatorcontrib><creatorcontrib>Demchuk, Andrew M.</creatorcontrib><creatorcontrib>HERMES Collaborators</creatorcontrib><creatorcontrib>on behalf of the HERMES Collaborators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Stroke (1970)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanaka, Koji</au><au>Goyal, Mayank</au><au>Menon, Bijoy K.</au><au>Campbell, Bruce C.V.</au><au>Mitchell, Peter J.</au><au>Jovin, Tudor G.</au><au>Dávalos, Antoni</au><au>Jansen, Olav</au><au>Muir, Keith W.</au><au>White, Phil M.</au><au>Bracard, Serge</au><au>Achit, Hamza</au><au>Dippel, Diederik W.J.</au><au>Majoie, Charles B.L.M.</au><au>Hill, Michael D.</au><au>Brown, Scott</au><au>Demchuk, Andrew M.</au><aucorp>HERMES Collaborators</aucorp><aucorp>on behalf of the HERMES Collaborators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials</atitle><jtitle>Stroke (1970)</jtitle><addtitle>Stroke</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>53</volume><issue>12</issue><spage>3564</spage><epage>3571</epage><pages>3564-3571</pages><issn>0039-2499</issn><eissn>1524-4628</eissn><abstract>Age and infarct volume are strong predictors of outcome in patients with ischemic stroke who underwent endovascular therapy (EVT). We aimed to investigate the impact of ischemic core volume (ICV) on stroke outcome after EVT in elderly. Using the HERMES (Highly Effective Reperfusion Using Multiple Endovascular Devices) collaboration, a patient-level meta-analysis of 7 randomized trials in which patients were enrolled from December 2010 to April 2015) dataset, we categorized patients into those aged &lt;75 and ≥75 years. ICV was calculated on computed tomography perfusion or magnetic resonance diffusion-weighted imaging. The association between ICV and the benefit of EVT over best medical treatment on outcome (modified Rankin Scale [mRS] at 90 days) and an ICV threshold for high likelihood (≥90%) of very poor outcome (mRS score ≥5) after EVT were investigated. A total of 899 patients who had baseline ICV data, 247 patients aged ≥75 years, of which 118 were randomized in the EVT arm. Patients aged ≥75 years required smaller ICV to achieve mRS score ≤3 than those aged &lt;75 years in the EVT arm (median 10.7 mL versus 23.9 mL, &lt;0.001). In patients aged ≥75 years, modeling of outcome in both treatment arms revealed potential loss of effect for EVT at ICV of ≥50 mL or ≥85 mL for achieving mRS score ≤3 or ≤4, respectively. Treatment effect of EVT was significant in ICV &lt;50 mL for mRS ≤3 (odds ratio 2.38, 95% confidence interval 1.35-4.22). ICV ≥132 mL was a threshold for high likelihood of very poor outcome after EVT. However, EVT still predicted at least 30% rate of mRS ≤3 at 150 mL ICV if near-complete or complete reperfusion was achieved. Baseline ICV has an impact on stroke outcome after EVT in the elderly, but elderly patients with large ICV may still benefit from EVT if near-complete or complete reperfusion is achieved. Young patients seem to benefit from EVT regardless of ICV status.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>36337054</pmid><doi>10.1161/STROKEAHA.122.039774</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-4930-7789</orcidid><orcidid>https://orcid.org/0000-0001-6501-4057</orcidid><orcidid>https://orcid.org/0000-0003-2949-5679</orcidid><orcidid>https://orcid.org/0000-0002-3466-496X</orcidid><orcidid>https://orcid.org/0000-0002-6269-1543</orcidid><orcidid>https://orcid.org/0000-0001-9535-022X</orcidid><orcidid>https://orcid.org/0000-0003-3632-9433</orcidid><orcidid>https://orcid.org/0000-0002-2619-6975</orcidid><orcidid>https://orcid.org/0000-0001-9060-2109</orcidid><orcidid>https://orcid.org/0000-0002-0040-3251</orcidid><orcidid>https://orcid.org/0000-0002-8337-7529</orcidid><orcidid>https://orcid.org/0000-0002-7600-9568</orcidid><orcidid>https://orcid.org/0000-0002-9234-3515</orcidid><orcidid>https://orcid.org/0000-0002-7330-1942</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0039-2499
ispartof Stroke (1970), 2022-12, Vol.53 (12), p.3564-3571
issn 0039-2499
1524-4628
language eng
recordid cdi_proquest_miscellaneous_2733201921
source Alma/SFX Local Collection
subjects Aged
Brain Ischemia - diagnostic imaging
Brain Ischemia - surgery
Endovascular Procedures - methods
Humans
Randomized Controlled Trials as Topic
Reperfusion
Stroke - diagnostic imaging
Stroke - surgery
Thrombectomy - methods
Treatment Outcome
title Significance of Baseline Ischemic Core Volume on Stroke Outcome After Endovascular Therapy in Patients Age ≥75 Years: A Pooled Analysis of Individual Patient Data From 7 Trials
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A20%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Significance%20of%20Baseline%20Ischemic%20Core%20Volume%20on%20Stroke%20Outcome%20After%20Endovascular%20Therapy%20in%20Patients%20Age%20%E2%89%A575%20Years:%20A%20Pooled%20Analysis%20of%20Individual%20Patient%20Data%20From%207%20Trials&rft.jtitle=Stroke%20(1970)&rft.au=Tanaka,%20Koji&rft.aucorp=HERMES%20Collaborators&rft.date=2022-12-01&rft.volume=53&rft.issue=12&rft.spage=3564&rft.epage=3571&rft.pages=3564-3571&rft.issn=0039-2499&rft.eissn=1524-4628&rft_id=info:doi/10.1161/STROKEAHA.122.039774&rft_dat=%3Cproquest_cross%3E2733201921%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4497-8451f52cc9c10ca2246d07d9b8a193d3cc64c196f284d5e44a9dfd99d053d8d33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2733201921&rft_id=info:pmid/36337054&rfr_iscdi=true